PH16105A - Antiinflammatory 4,5-diaryl-alpha-(polyfluoroalkyl)-1h pyrrole-2-methanamines - Google Patents

Antiinflammatory 4,5-diaryl-alpha-(polyfluoroalkyl)-1h pyrrole-2-methanamines

Info

Publication number
PH16105A
PH16105A PH25506A PH25506A PH16105A PH 16105 A PH16105 A PH 16105A PH 25506 A PH25506 A PH 25506A PH 25506 A PH25506 A PH 25506A PH 16105 A PH16105 A PH 16105A
Authority
PH
Philippines
Prior art keywords
methanamines
polyfluoroalkyl
diaryl
antiinflammatory
pyrrole
Prior art date
Application number
PH25506A
Other languages
English (en)
Inventor
Saul Carl Cherkofsky
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of PH16105A publication Critical patent/PH16105A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH25506A 1980-04-18 1981-04-15 Antiinflammatory 4,5-diaryl-alpha-(polyfluoroalkyl)-1h pyrrole-2-methanamines PH16105A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14166480A 1980-04-18 1980-04-18
US06/237,638 US4335136A (en) 1980-04-18 1981-03-04 Anti-inflammatory 4,5-diaryl-α-(polyfluoroalkyl)-1H-pyrrole-2-methanamines

Publications (1)

Publication Number Publication Date
PH16105A true PH16105A (en) 1983-06-30

Family

ID=26839336

Family Applications (1)

Application Number Title Priority Date Filing Date
PH25506A PH16105A (en) 1980-04-18 1981-04-15 Antiinflammatory 4,5-diaryl-alpha-(polyfluoroalkyl)-1h pyrrole-2-methanamines

Country Status (17)

Country Link
US (1) US4335136A (fr)
EP (1) EP0038536B1 (fr)
AR (1) AR228270A1 (fr)
AU (1) AU540024B2 (fr)
CA (1) CA1144551A (fr)
DE (1) DE3162089D1 (fr)
DK (1) DK159681A (fr)
ES (1) ES8206465A1 (fr)
FI (1) FI811191L (fr)
GR (1) GR74514B (fr)
HU (1) HU184851B (fr)
IL (1) IL62660A (fr)
NO (1) NO811321L (fr)
NZ (1) NZ196860A (fr)
PH (1) PH16105A (fr)
PT (1) PT72883B (fr)
YU (1) YU100381A (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477463A (en) * 1982-05-10 1984-10-16 E. I. Du Pont De Nemours And Company Antiinflammatory and/or analgesic 1-alkyl-4,5-diaryl-2-fluoroalkyl-1H-pyrroles
US4652582A (en) * 1985-01-09 1987-03-24 E. I. Du Pont De Nemours And Company Antiinflammatory-2-halo-4,5-diarylpyrroles
US5908858A (en) 1996-04-05 1999-06-01 Sankyo Company, Limited 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
ES2208964T3 (es) * 1996-12-10 2004-06-16 G.D. SEARLE & CO. Compuestos de pirrolilo substituidos para el tratamiento de la inflamacion.
US6294568B1 (en) 1997-12-26 2001-09-25 Nissin Food Products Co., Ltd. 5-arylpyrrole derivatives
DE19963174A1 (de) 1999-12-27 2001-07-12 Gruenenthal Gmbh Substituierte Pyrrol-Mannichbasen
DE10261130A1 (de) * 2002-12-20 2004-07-01 Grünenthal GmbH Arzneimittel enthaltend substituierte 2,5-Diaminomethyl-1H-pyrrole
FR2874012B1 (fr) * 2004-08-09 2008-08-22 Sanofi Synthelabo Derives de pyrrole, leur preparation et leur utlisation en therapeutique
FR2887548B1 (fr) * 2005-06-27 2007-09-21 Sanofi Aventis Sa Derives de 4,5-diarylpyrrole, leur preparation et leur application en therapeutique
CN101801188A (zh) 2007-07-12 2010-08-11 特拉加拉医药品公司 治疗癌症、肿瘤和肿瘤相关性疾病的方法和组合物
EP3561023B1 (fr) * 2016-12-21 2022-10-12 Kyushu University National University Corporation Matériau luminescent, composé et élément luminescent organique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3564016A (en) * 1968-03-07 1971-02-16 Endo Lab Method of decarbonylation
US3709906A (en) * 1968-07-26 1973-01-09 Sankyo Co 2-alkyl-4,5-diphenylpyrrole derivatives
JPS4838705B1 (fr) * 1969-09-11 1973-11-19
JPS4843117B1 (fr) * 1969-09-16 1973-12-17
DE2062985A1 (de) * 1970-01-23 1971-07-29 Perstorp Ab Verfahren zur Herstellung von stabi len Trioxan Copolymeren
SE435278B (sv) * 1977-12-08 1984-09-17 Sagami Chem Res 5-cyano-1-legre(c?711?71-?714)alkyl-pyrrol-2-ettiksyra, framstellning derav och anvendningen som mellanprodukt vid framstellning av terapeutiskt verksamma pyrrolderivat

Also Published As

Publication number Publication date
DK159681A (da) 1981-10-19
PT72883B (en) 1983-02-28
CA1144551A (fr) 1983-04-12
AU6963281A (en) 1981-10-22
IL62660A0 (en) 1981-06-29
IL62660A (en) 1984-06-29
ES501432A0 (es) 1982-08-16
NO811321L (no) 1981-10-19
AU540024B2 (en) 1984-10-25
YU100381A (en) 1983-12-31
DE3162089D1 (de) 1984-03-08
US4335136A (en) 1982-06-15
EP0038536A1 (fr) 1981-10-28
GR74514B (fr) 1984-06-29
AR228270A1 (es) 1983-02-15
NZ196860A (en) 1984-05-31
EP0038536B1 (fr) 1984-02-01
ES8206465A1 (es) 1982-08-16
FI811191L (fi) 1981-10-19
PT72883A (en) 1981-05-01
HU184851B (en) 1984-10-29

Similar Documents

Publication Publication Date Title
JPS5753490A (en) 5'-aminoalkyl-4',4,8-trialkylpsoralens
GB2068382B (en) 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
EP0044486B1 (en) Antiinflammatory 4,5-diaryl-alpha-polyfluoroalkyl-1h-imidazole-2-methanamines
GB2073752B (en) 2,6-diaminobularines
PH16105A (en) Antiinflammatory 4,5-diaryl-alpha-(polyfluoroalkyl)-1h pyrrole-2-methanamines
GB2075012B (en) 4,1-benzoxazepines
GB2135303B (en) 3,5-dinitrophthalimides
AU547929B2 (en) 3,3-dimethylindolin-2-ones
AU541703B2 (en) 1,1-diacetoxyethane
PT73240A (en) 2,3-bis-hydroxybenzyl-derivatives
ZW6581A1 (en) 2,5-disubstituted-4-pirimidones
NZ197556A (en) 1,1 -alkylenediiminobis(4-( -aminoalkylamino)-anthraquinones
JPS56166118A (en) Antiinflammatory
AU546548B2 (en) 1,2,4-triazolylethylenes
JPS57116050A (en) 2,4-diamino-5-benzylpyrimidine
AU536894B2 (en) 4,9 - dioxonaphto-triazoles
ZA8165B (en) Antiinflammatory 4,5-diaryl-alpha-(polyhaloalkyl)-1h-imidazole-2-methanols
GB2086387B (en) 1,8-dihydroxy-9-anthrones
AU548045B2 (en) 2,3-dihydropyrans
GB2080791B (en) 1,4-benzoxazines
GB2086879B (en) 5-aryl-6h-1,3,4-thiadiazine-2-amines
ZA81222B (en) 1,3-diformyloxy -2-bromo-2-nitropropane
JPS56166193A (en) 1,4;3,6-dianhydro-2,5-diazido-2,5-dideoxy- hexitol
ZA812508B (en) Antiinflammatory 4,5-diaryl - a - (polyfluo-roalkyl)-1h-pyrrole-2-methanamines
ZA814912B (en) Antiinflammatory 4,5-diaryl-a-polyfluoroalkyl - 1h-imidazole-2-methanamines